That's our Co-PI, Mike Steinman on AMDA - The Society for PALTC Medicine's #Deprescribing podcast! Check it out!

Pharmacists in aged care is a really hot topic right now. Please share this event with your colleagues Jarrod McMaugh MPS Paul Wappett RACGP ANZSGM Amy Page

📣 #USDeN2023 is less than a month away!

Annual Meeting: May 3, 2023
Long Beach, California

Take a look at the amazing agenda with all-star presentations!

Haven't registered yet?

You can take care of that here: deprescribingresearch.org/network-activi…

Have you you signed up for our webinar about #Stakeholder #Engagement on 3/14 yet?

Honored to work on this interesting piece with my USDEN JII cohort and mentors US Deprescribing Research Network (USDeN) Mike Steinman Frank Moriarty @AnnaHung Veena Manja, MBBS, MSc, PhD Tesfahun C. Eshetie 🍊 Henok G. Tegegn Tim Anderson Thomas Radomski
agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…

Which #PROM is the most suitable to measure #MedicationAdherence for people with #CVD ?
#Psychometric properties, #ClinicalUtility / #Feasibility of #PROM s

Enjoy reading our #COSMIN #Review published in @ClinDrugInvestig

HealthUNE Uni of New England
link.springer.com/article/10.100…

📣International Society for Pharmacoepidemiology webinar Oct. 6th 12-1pm ET/9-10am PT!

'Is There a Role for Pharmacoepidemiology in #Deprescribing Research?'

w/Drs. #CarolineSirois , #SaschaDublin , Anton Pottegård, Daniela Moga & Andrew Zullo, PharmD

Register bit.ly/3qPQjqF
Cosponsors Australian Deprescribing Network (ADeN) US Deprescribing Research Network (USDeN)

Mike Steinman giving his wisdom, reflections and recommendations in deprescribing research in his closing keynote #ICOD2022
NERDeprescribing Australian Deprescribing Network (ADeN) US Deprescribing Research Network (USDeN) Deprescribing.org

Recommendations for outcome measurement in deprescribing trials - consensus results of extensive US Deprescribing Research Network (USDeN) working group process. Hot off the presses!

Great opportunities to guide future studies of deprescribing.

agsjournals.onlinelibrary.wiley.com/doi/epdf/10.11…

Comprehensive Geriatric Assessment for older people in the community at risk of poor health outcomes. This Cochrane EPOC systematic review evaluates the evidence from 21 studies. buff.ly/3lhVtcu Cochrane Campbell Global Ageing Partnership
#HealthyAgeing

Tomorrow, 5/19 at 12pm ET/9am PT

#Deprescribing Education vs. Usual Care for Patients with #Cognitive Impairment

w/ #DrLizBayliss & Cynthia Boyd

Register here: bit.ly/3MXrJgA

It was a great experience to have met with stakeholders and learned their experience with and wonderful lessons on health taxes and laws on #NCDs risk factors in #Ethiopia .

Great!! Standardized definition help avoid inconsistency/heterogeneity of
outcomes of #deprescribing . Hope it would facilitate its inclusion as a core outcome set for #deprescribing research for #metaanalysis and #ClinicalTrials

#USDEN2022LIVE US Deprescribing Research Network (USDeN)

#USDeN2022Live

13 #USDeNJIIs were selected for the 2022-2023 cohort! Tasce Bongiovanni, MD, MPP, MHS #DrMartinCasey Kaley Hayes, PharmD, PhD Daniel Hoyle Ｋａｔｈａｒｉｎａ Ｊｕｎｇｏ #DrJihaLee Veena Manja, MBBS, MSc, PhD Audrey D. Zhang Phương Phạm Nguyễn Henok G. Tegegn, PhD Jinjiao (Jasmine) Wang & #DrArmandoSilvaAlmodovar

#USDeN2022Live

#USDeN2022 is TODAY!

It's happening now in Orlando, Florida, in tandem with American Geriatrics Society #AGS22 !

Our Annual Network Meeting!

Stay tuned throughout the day as as Jen Croteau from BrownGerontology will be taking over our Twitter account for

#USDeN2022 Live!

Thrilled to have been selected as the #USDEN ’s #JII 2022-23 cohort member US Deprescribing Research Network (USDeN) and can't wait to meet #deprescribing #scholars and contribute to #deprescribing #research .

USDeN April Announcements! - mailchi.mp/c5e8cbcc1909/u…

#Deprescribing is an exciting area of #Research right now. Brilliant teams of researchers are conducting all kinds of studies from randomized trials to implementation science to observational big data--all with the goal of understanding how we can make a difference. Joshua Niznik, PharmD, PhD

#Deprescribing ResearchChat

'Every time we prescribe a new #Medication we should also think about when we can stop it.'

Insight from Amanda S. Mixon, Co-Lead of Pilot and Exploratory Studies Core for #USDeN .

Join us at our #TwitterChat to hear her drop more #Deprescribing wisdom.⬇️